BDBM72541 2-(2-imidazolin-2-ylthio)-N-[3-(trifluoromethyl)phenyl]acetamide;hydrochloride::2-(4,5-dihydro-1H-imidazol-2-ylsulfanyl)-N-[3-(trifluoromethyl)phenyl]acetamide;hydrochloride::2-(4,5-dihydro-1H-imidazol-2-ylsulfanyl)-N-[3-(trifluoromethyl)phenyl]ethanamide;hydrochloride::2-(4,5-dihydro-1H-imidazol-2-ylthio)-N-[3-(trifluoromethyl)phenyl]acetamide;hydrochloride::MLS000624487::SMR000323443::cid_16194782

SMILES COc1ncnc(C2CC2)c1-c1ncc2c3ccc(N(C)S(C)(=O)=O)cc3n(Cc3ccc4c(c3)CCCn3cc(C(F)(F)F)nc3-4)c2n1

InChI Key InChIKey=GSRUSEGVJQGBQN-UHFFFAOYSA-N

Data  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 72541   

TargetUbiquitin carboxyl-terminal hydrolase 1(Human)
Shanghai Qilu Pharmaceutical Research and Development Centre

US Patent
LigandChemical structure of BindingDB Monomer ID 72541BDBM72541(US20250368667, Compound 91)
Affinity DataIC50: 4.16nMAssay Description:Keywords: Heat Shock Factor-1 (HSF-1), Stress Response, MG132, NIH3T3, Luminescence Assay Overview: Modified NIH3T3, transformed to express firefly...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/15/2026
Entry Details
US Patent